Tickers

RKLB — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-22 08:35:15.041763 UTC · finished 2026-09-22 08:42:52.490481 UTC

1. Composite Trajectory Verdict

Given RKLB's high-growth, capital-intensive space launch and systems business, the income statement (margin trajectory) and balance sheet (liquidity and leverage) carry the most weight for assessing financial performance, while operating cash flow is expected to be negative during the heavy investment phase.

Composite Trajectory: Mixed

The income statement shows clear improvement: gross margin expanded from 21.0% (FY2023) to 34.4% (FY2025) and from 30.6% to 37.1% (YTD Q2), while operating loss margin narrowed from -72.8% to -38.1% annually and -44.5% to -26.1% YTD. The balance sheet strengthened dramatically: cash and marketable securities grew from $479.7M (Dec 2024) to $2,387.6M (Jun 2026), equity surged from $382.5M to $3,492.2M, and convertible notes were nearly eliminated ($345.4M → $13.1M). However, cash generation is deteriorating: operating cash flow worsened from -$48.9M (FY2024) to -$165.5M (FY2025) and from -$77.5M to -$134.4M (YTD Q2), with inventory ballooning 68% in six months to $266.9M.

2. Red Flags

  • Operating cash flow deteriorated sharply: FY2025 -$165.5M vs FY2024 -$48.9M (10-K FY2025, Consolidated Statements of Cash Flows); YTD Q2 2026 -$134.4M vs YTD Q2 2025 -$77.5M (10-Q Q2 2026, Consolidated Statements of Cash Flows).
  • Inventory surge: $158.4M at Dec 2025 → $266.9M at Jun 2026 (+68% in six months) (10-Q Q2 2026, Consolidated Balance Sheets).
  • R&D expense as % of revenue increased to 45.0% in FY2025 from 40.0% in FY2024 (10-K FY2025, Results of Operations).
  • Net loss widened in absolute terms annually: $182.6M (FY2023) → $190.2M (FY2024) → $198.2M (FY2025) (10-K FY2025, Consolidated Statements of Operations).
  • Significant shareholder dilution: weighted average shares outstanding rose from 481.8M (FY2023) to 530.7M (FY2025) to 598.2M outstanding at Jun 2026 (10-K FY2025 and 10-Q Q2 2026, Consolidated Statements of Operations / Balance Sheets).
  • Pending Iridium acquisition requires >$3B cash and a $3.6B bridge loan commitment (10-Q Q2 2026, Liquidity and Capital Resources).
  • Neutron first launch delayed to Q4 2026 with continued risk and uncertainty (10-Q Q2 2026, Recent Developments).
  • Goodwill increased from $71.0M (Dec 2024) to $205.8M (Dec 2025) to $299.1M (Jun 2026) through acquisitions (10-K FY2025 and 10-Q Q2 2026, Consolidated Balance Sheets).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Overall Assessment: Revenue growth remains strong at 38% YoY annually (FY2025 $601.8M vs FY2024 $436.2M) and 63% YoY for YTD Q2 2026 ($434.4M vs $267.1M) (10-K FY2025 and 10-Q Q2 2026, Consolidated Statements of Operations). Gross margin expanded from 21.0% (FY2023) to 34.4% (FY2025) and from 30.6% to 37.1% (YTD) (same sources). Operating loss margin improved from -72.8% to -38.1% annually and -44.5% to -26.1% YTD. Net loss margin improved from -74.7% to -33.1% annually and -47.6% to -21.7% YTD. However, absolute net loss increased slightly each full year, and R&D intensity rose to 45% of revenue in FY2025 from 40% in FY2024.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Overall Assessment: Operating cash flow has worsened significantly: FY2025 used $165.5M vs FY2024 $48.9M (10-K FY2025, Consolidated Statements of Cash Flows), and YTD Q2 2026 used $134.4M vs $77.5M prior year (10-Q Q2 2026, Consolidated Statements of Cash Flows). Investing outflows also grew due to capex ($156.3M FY2025; $53.1M YTD Q2 2026) and acquisitions ($132.4M for GEOST in FY2025; $44.3M YTD Q2 2026) (same sources). Financing inflows surged via ATM offerings ($1.12B FY2025; $1.51B YTD Q2 2026), masking operational cash burn. Implied free cash flow (operating minus capex) was -$321.8M FY2025 and -$187.5M YTD Q2 2026.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Overall Assessment: Liquidity strengthened dramatically: cash and marketable securities rose from $479.7M (Dec 2024) to $1,098.8M (Dec 2025) to $2,387.6M (Jun 2026) (10-K FY2025 and 10-Q Q2 2026, Consolidated Balance Sheets). Total equity increased from $382.5M to $1,721.9M to $3,492.2M over the same periods. Convertible senior notes declined from $345.4M (Dec 2024) to $152.4M (Dec 2025) to $13.1M (Jun 2026) due to conversions (same sources). Total assets more than doubled from $1.18B to $4.19B. Leverage (debt-to-equity) was nearly eliminated.

6. Data Gaps

  • Standalone quarterly operating cash flow for Q2 2026 and Q2 2025 (only YTD provided in 10-Q Q2 2026).
  • Segment-level operating income (Launch Services vs Space Systems) not disclosed in filings.
  • Free cash flow not explicitly reported; derived from operating cash flow less capex.
  • Detailed debt maturity schedule beyond convertible notes (only total minimum lease payments given).
  • Full-year 2026 guidance or updated Neutron CapEx expectations not in filings.
  • Q3 2025 and Q4 2025 standalone quarterly financial statements (only annual and YTD available).
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status